You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2023 to November 2024

AbstractFullPdf
Nov 2023220027
Dec 202386011
Jan 202475010
Feb 20249405
Mar 202456010
Apr 20247608
May 20247006
Jun 202456010
Jul 202494023
Aug 202494024
Sep 2024152025
Oct 2024132041
Nov 202480022
Total12850222